The IARC Perspective on Cervical Cancer Screening
Véronique BouvardAmerican Cancer Society (R. Smith), Emory University (M.H.C.), and Centers for Disease Control and Prevention (M. Saraiya), Atlanta, GA; Amsterdam University Medical Centers, Amsterdam, the Netherlands (J. Berkhof); Azienda Unità Sanitaria Locale, IRCCS Reggio Emilia, Reggio Emilia, Italy (P.G.-R.); Casablanca Cancer Registry, Casablanca, Morocco (K.B.); Center for the Study of the State and Society (S.A.), and National Scientific and Technical Research Council (S.A.), Buenos Aires, Argentina; Chinese Academy of Medical Sciences, Beijing, China (F.Z.); Hospital Clínic de Barcelona, Barcelona, Spain (M.d.P.); Hospital Universitario San Ignacio, Bogota, Colombia (R.M.); International Agency for Research on Cancer, Lyon (V.B., W.P., B.I.I.R., I.M.-M., B.L.-S.); Karolinska Institutet, Stockholm, Sweden (M.E.); McGill University, Montreal, Quebec, Canada (E.L.F.); National Cancer Institute, Bangkok, Thailand (S.S.); National Cancer Institute, Rockville, MD (N.W., M. Schiffman); National Public Health Agency, Saint-Maurice (F.F.H.), France; PATH, Seattle, WA (S.d.S.); Public Health England and Screening, London, United Kingdom (A.M.); Research Triangle Institute International, New Delhi, India (R. Sankaranarayanan); Teikyo University (C.H.), and National Cancer Center (C.H.), Tokyo, Japan; The Daffodil Centre, a joint venture between the Cancer Council NSW and the University of Sydney, King's Cross, New South Wales, Australia (K.C.); University of Edinburgh, Edinburgh, United Kingdom (C.S.H.); University of Toronto, Toronto, Ontario, Canada (R.K.); University of Zimbabwe College of Health Sciences, Harare, Zimbabwe (Z.M.C.); VCS Foundation, Melbourne, Victoria, Australia (J. Brotherton); and Sciensano, Brussels, Belgium (M.A.)Nicolas WentzensenChinese Academy of Medical Sciences & Peking Union Medical CollegeAnne MackieNational Cancer CenterJohannes BerkhofChinese Academy of Medical Sciences & Peking Union Medical CollegeJulia BrothertonAmerican Cancer Society (R. Smith), Emory University (M.H.C.), and Centers for Disease Control and Prevention (M. Saraiya), Atlanta, GA; Amsterdam University Medical Centers, Amsterdam, the Netherlands (J. Berkhof); Azienda Unità Sanitaria Locale, IRCCS Reggio Emilia, Reggio Emilia, Italy (P.G.-R.); Casablanca Cancer Registry, Casablanca, Morocco (K.B.); Center for the Study of the State and Society (S.A.), and National Scientific and Technical Research Council (S.A.), Buenos Aires, Argentina; Chinese Academy of Medical Sciences, Beijing, China (F.Z.); Hospital Clínic de Barcelona, Barcelona, Spain (M.d.P.); Hospital Universitario San Ignacio, Bogota, Colombia (R.M.); International Agency for Research on Cancer, Lyon (V.B., W.P., B.I.I.R., I.M.-M., B.L.-S.); Karolinska Institutet, Stockholm, Sweden (M.E.); McGill University, Montreal, Quebec, Canada (E.L.F.); National Cancer Institute, Bangkok, Thailand (S.S.); National Cancer Institute, Rockville, MD (N.W., M. Schiffman); National Public Health Agency, Saint-Maurice (F.F.H.), France; PATH, Seattle, WA (S.d.S.); Public Health England and Screening, London, United Kingdom (A.M.); Research Triangle Institute International, New Delhi, India (R. Sankaranarayanan); Teikyo University (C.H.), and National Cancer Center (C.H.), Tokyo, Japan; The Daffodil Centre, a joint venture between the Cancer Council NSW and the University of Sydney, King's Cross, New South Wales, Australia (K.C.); University of Edinburgh, Edinburgh, United Kingdom (C.S.H.); University of Toronto, Toronto, Ontario, Canada (R.K.); University of Zimbabwe College of Health Sciences, Harare, Zimbabwe (Z.M.C.); VCS Foundation, Melbourne, Victoria, Australia (J. Brotherton); and Sciensano, Brussels, Belgium (M.A.)Paolo Giorgi RossiAmsterdam University Medical CentersRachel KupetsNational Cancer CenterRobert A. SmithChinese Academy of Medical Sciences & Peking Union Medical CollegeSilvina ArrossiAmsterdam University Medical CentersKarima BendahhouAmsterdam University Medical CentersKaren CanfellChinese Academy of Medical Sciences & Peking Union Medical CollegeZvavahera M. ChirenjeChinese Academy of Medical Sciences & Peking Union Medical CollegeMichael H. ChungChinese Academy of Medical Sciences & Peking Union Medical CollegeMarta del PinoAmerican Cancer Society (R. Smith), Emory University (M.H.C.), and Centers for Disease Control and Prevention (M. Saraiya), Atlanta, GA; Amsterdam University Medical Centers, Amsterdam, the Netherlands (J. Berkhof); Azienda Unità Sanitaria Locale, IRCCS Reggio Emilia, Reggio Emilia, Italy (P.G.-R.); Casablanca Cancer Registry, Casablanca, Morocco (K.B.); Center for the Study of the State and Society (S.A.), and National Scientific and Technical Research Council (S.A.), Buenos Aires, Argentina; Chinese Academy of Medical Sciences, Beijing, China (F.Z.); Hospital Clínic de Barcelona, Barcelona, Spain (M.d.P.); Hospital Universitario San Ignacio, Bogota, Colombia (R.M.); International Agency for Research on Cancer, Lyon (V.B., W.P., B.I.I.R., I.M.-M., B.L.-S.); Karolinska Institutet, Stockholm, Sweden (M.E.); McGill University, Montreal, Quebec, Canada (E.L.F.); National Cancer Institute, Bangkok, Thailand (S.S.); National Cancer Institute, Rockville, MD (N.W., M. Schiffman); National Public Health Agency, Saint-Maurice (F.F.H.), France; PATH, Seattle, WA (S.d.S.); Public Health England and Screening, London, United Kingdom (A.M.); Research Triangle Institute International, New Delhi, India (R. Sankaranarayanan); Teikyo University (C.H.), and National Cancer Center (C.H.), Tokyo, Japan; The Daffodil Centre, a joint venture between the Cancer Council NSW and the University of Sydney, King's Cross, New South Wales, Australia (K.C.); University of Edinburgh, Edinburgh, United Kingdom (C.S.H.); University of Toronto, Toronto, Ontario, Canada (R.K.); University of Zimbabwe College of Health Sciences, Harare, Zimbabwe (Z.M.C.); VCS Foundation, Melbourne, Victoria, Australia (J. Brotherton); and Sciensano, Brussels, Belgium (M.A.)Silvia de SanjoséAmsterdam University Medical CentersMiriam ElfströmNational Cancer CenterEduardo L. FrancoChinese Academy of Medical Sciences & Peking Union Medical CollegeChisato HamashimaChinese Academy of Medical Sciences & Peking Union Medical CollegeF F HamersChinese Academy of Medical Sciences & Peking Union Medical CollegeC. Simon HerringtonAmerican Cancer Society (R. Smith), Emory University (M.H.C.), and Centers for Disease Control and Prevention (M. Saraiya), Atlanta, GA; Amsterdam University Medical Centers, Amsterdam, the Netherlands (J. Berkhof); Azienda Unità Sanitaria Locale, IRCCS Reggio Emilia, Reggio Emilia, Italy (P.G.-R.); Casablanca Cancer Registry, Casablanca, Morocco (K.B.); Center for the Study of the State and Society (S.A.), and National Scientific and Technical Research Council (S.A.), Buenos Aires, Argentina; Chinese Academy of Medical Sciences, Beijing, China (F.Z.); Hospital Clínic de Barcelona, Barcelona, Spain (M.d.P.); Hospital Universitario San Ignacio, Bogota, Colombia (R.M.); International Agency for Research on Cancer, Lyon (V.B., W.P., B.I.I.R., I.M.-M., B.L.-S.); Karolinska Institutet, Stockholm, Sweden (M.E.); McGill University, Montreal, Quebec, Canada (E.L.F.); National Cancer Institute, Bangkok, Thailand (S.S.); National Cancer Institute, Rockville, MD (N.W., M. Schiffman); National Public Health Agency, Saint-Maurice (F.F.H.), France; PATH, Seattle, WA (S.d.S.); Public Health England and Screening, London, United Kingdom (A.M.); Research Triangle Institute International, New Delhi, India (R. Sankaranarayanan); Teikyo University (C.H.), and National Cancer Center (C.H.), Tokyo, Japan; The Daffodil Centre, a joint venture between the Cancer Council NSW and the University of Sydney, King's Cross, New South Wales, Australia (K.C.); University of Edinburgh, Edinburgh, United Kingdom (C.S.H.); University of Toronto, Toronto, Ontario, Canada (R.K.); University of Zimbabwe College of Health Sciences, Harare, Zimbabwe (Z.M.C.); VCS Foundation, Melbourne, Victoria, Australia (J. Brotherton); and Sciensano, Brussels, Belgium (M.A.)Raúl MurilloNational Cancer CenterSuleeporn SangrajrangAmsterdam University Medical CentersRengaswamy SankaranarayananAmerican Cancer Society (R. Smith), Emory University (M.H.C.), and Centers for Disease Control and Prevention (M. Saraiya), Atlanta, GA; Amsterdam University Medical Centers, Amsterdam, the Netherlands (J. Berkhof); Azienda Unità Sanitaria Locale, IRCCS Reggio Emilia, Reggio Emilia, Italy (P.G.-R.); Casablanca Cancer Registry, Casablanca, Morocco (K.B.); Center for the Study of the State and Society (S.A.), and National Scientific and Technical Research Council (S.A.), Buenos Aires, Argentina; Chinese Academy of Medical Sciences, Beijing, China (F.Z.); Hospital Clínic de Barcelona, Barcelona, Spain (M.d.P.); Hospital Universitario San Ignacio, Bogota, Colombia (R.M.); International Agency for Research on Cancer, Lyon (V.B., W.P., B.I.I.R., I.M.-M., B.L.-S.); Karolinska Institutet, Stockholm, Sweden (M.E.); McGill University, Montreal, Quebec, Canada (E.L.F.); National Cancer Institute, Bangkok, Thailand (S.S.); National Cancer Institute, Rockville, MD (N.W., M. Schiffman); National Public Health Agency, Saint-Maurice (F.F.H.), France; PATH, Seattle, WA (S.d.S.); Public Health England and Screening, London, United Kingdom (A.M.); Research Triangle Institute International, New Delhi, India (R. Sankaranarayanan); Teikyo University (C.H.), and National Cancer Center (C.H.), Tokyo, Japan; The Daffodil Centre, a joint venture between the Cancer Council NSW and the University of Sydney, King's Cross, New South Wales, Australia (K.C.); University of Edinburgh, Edinburgh, United Kingdom (C.S.H.); University of Toronto, Toronto, Ontario, Canada (R.K.); University of Zimbabwe College of Health Sciences, Harare, Zimbabwe (Z.M.C.); VCS Foundation, Melbourne, Victoria, Australia (J. Brotherton); and Sciensano, Brussels, Belgium (M.A.)Mona SaraiyaAmerican Cancer Society (R. Smith), Emory University (M.H.C.), and Centers for Disease Control and Prevention (M. Saraiya), Atlanta, GA; Amsterdam University Medical Centers, Amsterdam, the Netherlands (J. Berkhof); Azienda Unità Sanitaria Locale, IRCCS Reggio Emilia, Reggio Emilia, Italy (P.G.-R.); Casablanca Cancer Registry, Casablanca, Morocco (K.B.); Center for the Study of the State and Society (S.A.), and National Scientific and Technical Research Council (S.A.), Buenos Aires, Argentina; Chinese Academy of Medical Sciences, Beijing, China (F.Z.); Hospital Clínic de Barcelona, Barcelona, Spain (M.d.P.); Hospital Universitario San Ignacio, Bogota, Colombia (R.M.); International Agency for Research on Cancer, Lyon (V.B., W.P., B.I.I.R., I.M.-M., B.L.-S.); Karolinska Institutet, Stockholm, Sweden (M.E.); McGill University, Montreal, Quebec, Canada (E.L.F.); National Cancer Institute, Bangkok, Thailand (S.S.); National Cancer Institute, Rockville, MD (N.W., M. Schiffman); National Public Health Agency, Saint-Maurice (F.F.H.), France; PATH, Seattle, WA (S.d.S.); Public Health England and Screening, London, United Kingdom (A.M.); Research Triangle Institute International, New Delhi, India (R. Sankaranarayanan); Teikyo University (C.H.), and National Cancer Center (C.H.), Tokyo, Japan; The Daffodil Centre, a joint venture between the Cancer Council NSW and the University of Sydney, King's Cross, New South Wales, Australia (K.C.); University of Edinburgh, Edinburgh, United Kingdom (C.S.H.); University of Toronto, Toronto, Ontario, Canada (R.K.); University of Zimbabwe College of Health Sciences, Harare, Zimbabwe (Z.M.C.); VCS Foundation, Melbourne, Victoria, Australia (J. Brotherton); and Sciensano, Brussels, Belgium (M.A.)Mark SchiffmanAmerican Cancer Society (R. Smith), Emory University (M.H.C.), and Centers for Disease Control and Prevention (M. Saraiya), Atlanta, GA; Amsterdam University Medical Centers, Amsterdam, the Netherlands (J. Berkhof); Azienda Unità Sanitaria Locale, IRCCS Reggio Emilia, Reggio Emilia, Italy (P.G.-R.); Casablanca Cancer Registry, Casablanca, Morocco (K.B.); Center for the Study of the State and Society (S.A.), and National Scientific and Technical Research Council (S.A.), Buenos Aires, Argentina; Chinese Academy of Medical Sciences, Beijing, China (F.Z.); Hospital Clínic de Barcelona, Barcelona, Spain (M.d.P.); Hospital Universitario San Ignacio, Bogota, Colombia (R.M.); International Agency for Research on Cancer, Lyon (V.B., W.P., B.I.I.R., I.M.-M., B.L.-S.); Karolinska Institutet, Stockholm, Sweden (M.E.); McGill University, Montreal, Quebec, Canada (E.L.F.); National Cancer Institute, Bangkok, Thailand (S.S.); National Cancer Institute, Rockville, MD (N.W., M. Schiffman); National Public Health Agency, Saint-Maurice (F.F.H.), France; PATH, Seattle, WA (S.d.S.); Public Health England and Screening, London, United Kingdom (A.M.); Research Triangle Institute International, New Delhi, India (R. Sankaranarayanan); Teikyo University (C.H.), and National Cancer Center (C.H.), Tokyo, Japan; The Daffodil Centre, a joint venture between the Cancer Council NSW and the University of Sydney, King's Cross, New South Wales, Australia (K.C.); University of Edinburgh, Edinburgh, United Kingdom (C.S.H.); University of Toronto, Toronto, Ontario, Canada (R.K.); University of Zimbabwe College of Health Sciences, Harare, Zimbabwe (Z.M.C.); VCS Foundation, Melbourne, Victoria, Australia (J. Brotherton); and Sciensano, Brussels, Belgium (M.A.)Fanghui ZhaoChinese Academy of Medical Sciences & Peking Union Medical CollegeMarc ArbynAmerican Cancer Society (R. Smith), Emory University (M.H.C.), and Centers for Disease Control and Prevention (M. Saraiya), Atlanta, GA; Amsterdam University Medical Centers, Amsterdam, the Netherlands (J. Berkhof); Azienda Unità Sanitaria Locale, IRCCS Reggio Emilia, Reggio Emilia, Italy (P.G.-R.); Casablanca Cancer Registry, Casablanca, Morocco (K.B.); Center for the Study of the State and Society (S.A.), and National Scientific and Technical Research Council (S.A.), Buenos Aires, Argentina; Chinese Academy of Medical Sciences, Beijing, China (F.Z.); Hospital Clínic de Barcelona, Barcelona, Spain (M.d.P.); Hospital Universitario San Ignacio, Bogota, Colombia (R.M.); International Agency for Research on Cancer, Lyon (V.B., W.P., B.I.I.R., I.M.-M., B.L.-S.); Karolinska Institutet, Stockholm, Sweden (M.E.); McGill University, Montreal, Quebec, Canada (E.L.F.); National Cancer Institute, Bangkok, Thailand (S.S.); National Cancer Institute, Rockville, MD (N.W., M. Schiffman); National Public Health Agency, Saint-Maurice (F.F.H.), France; PATH, Seattle, WA (S.d.S.); Public Health England and Screening, London, United Kingdom (A.M.); Research Triangle Institute International, New Delhi, India (R. Sankaranarayanan); Teikyo University (C.H.), and National Cancer Center (C.H.), Tokyo, Japan; The Daffodil Centre, a joint venture between the Cancer Council NSW and the University of Sydney, King's Cross, New South Wales, Australia (K.C.); University of Edinburgh, Edinburgh, United Kingdom (C.S.H.); University of Toronto, Toronto, Ontario, Canada (R.K.); University of Zimbabwe College of Health Sciences, Harare, Zimbabwe (Z.M.C.); VCS Foundation, Melbourne, Victoria, Australia (J. Brotherton); and Sciensano, Brussels, Belgium (M.A.)Walter PrendivilleChinese Academy of Medical Sciences & Peking Union Medical CollegeBlanca I. Indave RuizNational Cancer CenterIsabel Mosquera-MetcalfeAmsterdam University Medical CentersBéatrice Lauby-SecretanChinese Academy of Medical Sciences & Peking Union Medical College
2022en
Ochiq kirish: yoʻq
ABI
Annotatsiya
(Abstracted from N Engl J Med 2021;385:1908–1918) In May 2018, the World Health Organization (WHO) called for the elimination of global cervical cancer as a major public health priority, with a 2-pronged approach focusing on effective vaccination against human papillomavirus (HPV) and the screening for and treatment of early cervical cancer. Cervical cancer is considered largely preventable through these programs; however, it continues to be disproportionately prevalent in countries with the lowest values on the Human Development Index.
Hali tarjima qilinmagan
Identifikatorlar
Iqtiboslar va manbalar
2 ta iqtibos0 ta foydalanilgan manba